Key points are not available for this paper at this time.
Worldwide, breast cancer (BC) is one of the most commonly diagnosed malignancies in women. Early detection is key to improving survival rates and health outcomes. This literature review focuses on how artificial intelligence (AI), especially deep learning (DL), can enhance the ability of mammography, a key tool in BC detection, to yield more accurate results. Artificial intelligence has shown promise in reducing diagnostic errors and increasing early cancer detection chances. Nevertheless, significant challenges exist, including the requirement for large amounts of high-quality data and concerns over data privacy. Despite these hurdles, AI and DL are advancing the field of radiology, offering better ways to diagnose, detect, and treat diseases. The U.S. Food and Drug Administration (FDA) has approved several AI diagnostic tools. Yet, the full potential of these technologies, especially for more advanced screening methods like digital breast tomosynthesis (DBT), depends on further clinical studies and the development of larger databases. In summary, this review highlights the exciting potential of AI in BC screening. It calls for more research and validation to fully employ the power of AI in clinical practice, ensuring that these technologies can help save lives by improving diagnosis accuracy and efficiency.
Muhaisen et al. (2024) studied this question.